Related Experiment Video

Updated: May 31, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Selective gene expression profiling of mTOR-associated tumor suppressor and oncogenes in ovarian cancer

Piotr Laudański1, Oksana Kowalczuk, Dagmara Klasa-Mazurkiewicz

  • 1Department of Perinatology, Medical University of Bialystok, Poland. plauda@umwb.edu.pl

Folia Histochemica Et Cytobiologica
|July 12, 2011
PubMed

Insights

This study investigated mammalian target of rapamycin (mTOR)-related genes in ovarian cancer. Key tumor suppressor genes PTEN, TP53, PIK3CA, and BECN1 were significantly downregulated in cancer patients, suggesting a role in ovarian cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer pathogenesis involves complex genetic alterations.
  • Mammalian target of rapamycin (mTOR) pathway dysregulation is implicated in various cancers.
  • Profiling oncogenes and tumor suppressor genes (TSGs) is crucial for understanding cancer development.

Purpose of the Study:

  • To selectively profile the activation status of mTOR-associated oncogenes and TSGs in ovarian cancer.
  • To compare gene expression in ovarian cancer, benign ovarian tumors, and healthy ovaries.
  • To identify potential biomarkers for ovarian cancer.

Main Methods:

  • Utilized a novel microfluidic gene array to examine 15 human tumor suppressors and oncogenes.
  • Analyzed gene expression in 53 ovarian cancer specimens, 29 benign ovarian cysts, and 11 healthy ovaries.
  • Performed confirmatory immunohistochemical detection for selected proteins.

Main Results:

  • Significant downregulation of PTEN (p < 0.0001), TP53 (p = 0.0003), PIK3CA (p = 0.0003), and BECN1 (p = 0.0014) in ovarian cancer compared to healthy and benign tissues.
  • These downregulated markers did not correlate with tumor grade or stage.
  • Immunohistochemistry confirmed the expression of PTEN, TP53, PIK3CA, and BECN1 proteins in ovarian cancer.

Conclusions:

  • Identified significant differences in mTOR-related tumor suppressor and oncogene expression in ovarian cancer.
  • PTEN, TP53, PIK3CA, and BECN1 downregulation may be associated with ovarian cancer pathogenesis.
  • These genes represent potential targets for further research and therapeutic strategies.

More Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...